The Food and Drug Administration (FDA) is classifying Clostridium difficile (C. difficile) toxin gene amplification assay into class II (special controls). The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
Document
Medical Devices; Immunology and Microbiology Devices; Classification of Clostridium Difficile Toxin Gene Amplification Assay
The Food and Drug Administration (FDA) is classifying Clostridium difficile (C. difficile) toxin gene amplification assay into class II (special controls). The Agency is classif...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 51938
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Medical Devices; Immunology and Microbiology Devices; Classification of Clostridium Difficile Toxin Gene Amplification Assay,” thefederalregister.org (August 27, 2015), https://thefederalregister.org/documents/2015-21237/medical-devices-immunology-and-microbiology-devices-classification-of-clostridium-difficile-toxin-gene-amplification-ass.